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Feed additives for the control 
of post‑weaning Streptococcus suis 
disease and the effect on the faecal 
and nasal microbiota
Florencia Correa‑Fiz1,2, Carlos Neila‑Ibáñez1,2, Sergio López‑Soria1,2, Sebastian Napp1,2, 
Blanca Martinez3, Laia Sobrevia3, Simon Tibble3, Virginia Aragon1,2 & 
Lourdes Migura‑Garcia1,2*
Medicated feed is a common strategy to control the occurrence of Streptococcus suis disease in swine 
production, but feed additives may constitute an alternative to metaphylaxis. In a farm with post‑
weaning S. suis disease, the following additives were tested: lysozyme (Lys), medium chain fatty acids 
plus lysozyme (FA + Lys), FA plus a natural anti‑inflammatory (FA + antiinf) and amoxicillin (Amox). 
During the course of the study, FA + antiinf and Amox groups showed lower prevalence of clinical signs 
compatible with S. suis disease than the rest of the groups. Piglets from the FA + antiinf group showed 
high diversity and richness in their nasal and faecal microbiota. Diet supplements did not have major 
effects on the faecal microbiota, where the genus Mitsuokella was the only differentially present in 
the FA + Lys group. In the nasal microbiota, piglets from FA + antiinf presented higher differential 
abundance of a sequence variant from Ruminococcaceae and lower abundance of an unclassified genus 
from Weeksellaceae. In general, we detected more significant changes in the nasal than in the feacal 
microbiota, and found that parity of the dams affected the microbiota composition of their offspring, 
with piglets born to gilts exhibiting lower richness and diversity. Our results suggest that additives 
could be useful to control post‑weaning disease when removing antimicrobials in farms.
During the last decades, antimicrobials have been used in human and veterinary medicine for the treatment of 
bacterial infectious diseases. The excessive use of these drugs has increased the selective pressure causing the 
emergence of multi-drug resistant bacteria in both, human and veterinary  medicine1. For many years, conven-
tional farming and in particular, pig production has routinely controlled the occurrence and transmission of 
diseases during critical periods of the rearing cycle by medicating the whole herd, including healthy  animals2. 
Weaning represents one of these critical periods with the highest risk of enteric and respiratory diseases, com-
monly requiring the use of  antimicrobials3. After farrowing, litters are normally mixed and young piglets of 
approximately 21 days old, with an immature immune system, have to adapt to the new environment in combi-
nation with a change of diet from milk to dried feed. This situation leaves piglets vulnerable to infections caused 
by multiple pathogens, including Streptococcus suis.
S. suis is an early colonizer of the upper respiratory track (tonsils and nasal cavities) of young piglets. Virulent 
strains can cause severe outbreaks after weaning, when maternal antibodies are at the lowest  level4. Meningitis 
and septicaemia are the most severe manifestation of the disease, causing up to 30% mortality  rates5, but endo-
carditis, pneumonia and polyarthritis have also been  reported6. Diagnostic at the farm is generally performed 
by the veterinarian based on clinical signs and macroscopic lesions.
For many years, the first option to control the emergence and spread of S. suis has been the prescription of 
feed supplemented with antimicrobials, generally a beta-lactam such as penicillin or  amoxicillin7. Nowadays, due 
to the emergence of multi-drug resistant bacteria, this use has to be well justified, and national action plans are 
focused on implementing antimicrobial stewardship strategies to minimise the consumption of antimicrobials in 
food producing  animals8 Different strategies have been suggested to comply with this new framework and reduce 
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the use of antimicrobials. Optimization of nutritional programs during the post-weaning period can favour the 
growth of beneficial bacteria resulting in a positive effect in the immune system of the animals and their  health9,10.
With the objective of removing the use of amoxicillin, this study aimed to assess the effect of three different 
combinations of feed additives during post-weaning on the occurrence of disease caused by S. suis. Clinical signs, 
faecal and nasal microbiota composition together with production parameters were compared among groups of 
piglets fed with the different additives and those treated with amoxicillin.
Results
Clinical status and productive performance. A total of 569 twenty-one days-old piglets were divided 
into 5 treatment groups (lysozyme (Lys), medium chain fatty acids and lysozyme (FA + Lys), FA and a natural 
anti-inflammatory (FA + antiinf), amoxicillin (Amox) and negative control). One week before weaning, the aver-
age weight per animal in each group was 4 kg. During the course of the study, 135 animals were removed from 
the five treatment groups due to different clinical signs (Table 1). The majority of the piglets removed (60.7%) 
exhibited clinical signs compatible with S. suis disease, such as limping or nervous signs. Coughing and wasting 
were also detected but with less frequency, 20.3% and 13.7% in FA + antiinf and control groups, respectively.
The differences in the prevalence of clinical signs compatible with S. suis (S. suis-like) in the FA + Lys and 
FA + antiinf groups (12.7% and 9.2%, respectively) compared with the prevalence in the amoxicillin group (9.6%) 
(Table 1), were not statistically significant (P = 0.45 and P = 0.93, respectively). In the case of the Lys group, the 
prevalence of S. suis-like clinical signs was higher (17.7%), and compared with the prevalence in the Amox 
group, the difference was close to being statistically significant (P = 0.07). On the other hand, comparisons of 
the prevalences of S. suis-like clinical signs in the treatment groups with the prevalence in the negative control 
group (22.3%) (Table 1), indicate that the differences were statistically significant for the FA + Lys group (preva-
lence = 12.7%; P = 0.06) and for the FA + antiinf group (prevalence = 9.2%; P = 0.006), but not for the Lysozyme 
group (prevalence = 17.7%; P = 0.39).
Throughout the study, 24% of the animals (4, 6, 14, 11 and 19 animals from the Lys, FA + lys, control, Amox 
and FA + antiinf groups, respectively) were removed due to the presence of any clinical sign. The prevalence of 
diseases in the Lys (21.2%), FA + Lys (18.2%) and FA + antiinf (25.2%) groups were not significantly different 
(P = 0.69, P = 0.86 and P = 0.26, respectively) compared to the prevalence in the Amox group (19.1%) (Table 1). 
Finally, comparisons of the prevalence of diseases in the groups fed with additives with the prevalence in the 
negative control group (34.8%, Table 1), indicated that the differences were statistically significant for the Lys 
group (prevalence = 21.2%; P = 0.02) and for the FA + Lys group (prevalence = 18.2%; P = 0.005), but not for the 
FA + antiinf group (prevalence = 25.2%; P = 0.11).
The average daily weight gain by the end of the transition-period in the different treatment groups was 
between 305.2 and 320.1 g. The Shapiro–Wilk test indicated that weights in the different groups were normally 
distributed and the ANOVA test demonstrated no significant differences in average daily weight gain (ADWG) 
among the five treatment groups (P = 0.67, Fig. 1).
Occurrence of S. suis and Glaesserella parasuis in the farm. Three animals from the non-treated 
control, Amox and AF + antiinf groups were sacrificed. The post-mortem examination showed that the piglets 
from the control and FA + antiinf groups exhibited lesions compatible with S. suis or G. parasuis infection. S. 
suis was confirmed as the cause of the disease at the farm, since a serotype 2 strain was isolated from the lesions 
of these two animals, confirming the circulation of the pathogen during the study period. G. parasuis was not 
isolated from any of the lesions from the euthanised piglets. The two S. suis isolates obtained from the lesions 
were susceptible to penicillin, ampicillin and ceftiofur. Both of them exhibited the same resistance profile, being 
phenotypically resistant to chlortetracycline (MIC ≥ 16), oxytetracycline (MIC ≥ 16), clindamycin (> 16), neomy-
cin (MIC ≥ 32), tylosin tartrate (MIC > 32) and tulathromycin (MIC > 64). These two isolates showed the same 
fingerprinting profile by Enterobacterial Repetitive Intergenic Consensus (ERIC) PCR.
PCR performed on nasal swabs taken at weaning (D0) from 123 piglets out of the subset of 125 (2 nasal swabs 
were mislabeled), demonstrated the presence of S. suis in the nasal cavities of 121 piglets. The two S. suis-negative 
piglets were from different litters. On D43, 102 individual piglets of the subset of 125 still included in the study 
were swabbed before departure to the finishing farm, and only one was negative for the presence of S. suis. This 
animal belonged to the group treated with amoxicillin, and was different to the two negative animals detected 
Table 1.  Number of animals that needed to be removed from each of the treatment groups including clinical 
signs compatible with infection caused by S. suis, and prevalence of disease in each treatment group. a Includes 
clinical sings compatible with S. suis (limping and nervous signs), coughing, wasting and diarrhea.
Treatments
Initial number of 
animals per group
Final number of animals 
per group
S. suis-like (limping and 
nervous) signs
Prevalence of S. suis-like 
clinical signs
Number of animals 
 removeda Prevalence of disease
Lysozyme 113 89 20 17.7 24 21.2
FA + lys 110 90 14 12.7 20 18.2
Negative control 112 73 25 22.3 39 34.8
Amoxicillin 115 93 11 9.6 22 19.1
FA + antiinf 119 89 11 9.2 30 25.2
Total 569 434 82 14.4 135 23.7
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during nursing. No association could be found between the presence of S. suis in the nasal samples and the treat-
ment groups. For G. parasuis, the initial prevalence of virulent strains based on the 123 piglets analysed by PCR 
was 37.2%. This prevalence increased at the end of the nursery period, with 98 animals carrying virulent strains 
out of the 102 analysed (96.1%). This is the expected dynamics of nasal colonization in piglets by G. parasuis, with 
increasing occurrence of G. parasuis with age during the nursery period. No association was detected between 
treatment group and the presence of G. parasuis virulent strains.
Changes in faecal and nasal microbiota composition through time. The V3-V4 region of the 16S 
rRNA gene was analysed to unravel the microbial composition in both faeces and nasal cavities of the pigs under 
treatment. Faecal content and nasal swabs taken from 12 piglets at weaning (D0, before treatment) and 10 piglets 
from each group at 21 days-post-treatment (D21) were included in the analysis. After quality control and filter-
ing steps, the mean frequency of sequences for rectal and nasal samples were 44,184 and 84,429, respectively.
Alpha diversity, measured by the Shannon index, of the faecal microbiota increased from D0 to D21 (Fig. 2A; 
Shannon, P = 0.000001), together with the richness (Chao, P = 0.00002). The same trend was observed in the nasal 
microbiota, where alpha diversity (Fig. 2B; Shannon, P = 0.000006) and richness (Chao, P = 0.017) also increased 
significantly during the study.
Beta diversity analysis showed a clear clustering of the faecal microbiota composition on D0 and D21, with 
the quantitative analysis explaining better the differences between the composition at these two timepoints (Bray 
Curtis  R2 = 10.10%, Fig. 2C; Jaccard  R2 = 8.58%; P = 0.001). Regarding the nasal microbiota, beta diversity analysis 
showed differential clustering by both Bray–Curtis and Jaccard indexes, where the difference explained by this 
grouping was also higher in the quantitative approach (Bray Curtis  R2 = 33.50%, Fig. 2D; Jaccard  R2 = 12.54%; 
P = 0.001). In order to detect differences in microbial mean taxa abundance over time, we performed the analysis 
of composition of microbiomes (ANCOM) that is based in the assumption that inter-taxa ratios are maintained 
for non-differentially abundant taxa. ANCOM performed at genus level detected 20 genera in faeces and 37 in 
nasal microbiota composition that dynamically changed over time (Supplementary Table S1).
Alpha diversity of faecal and nasal microbiota composition after treatments. Differences in 
diversity among treatments were explored by comparing the microbiota composition after 3 weeks of treatment 
(D21). Alpha diversity of the faecal microbiota was significantly lower in the Amox group when compared to 
the control group (Fig. 3A, P = 0.01) and demonstrated a tendency of being lower than the diversity found in the 
group FA + antiinf (P = 0.06). When the parity of the dams (gilts vs sows) was considered in the analysis, piglets 
born to sows from the Amox group showed lower diversity than pigs from control and FA + antiinf groups born 
to sows (Fig. 3B). Alpha diversity from the piglets born to sows from the FA + Lys group showed a tendency to 
be lower than the diversity observed in the piglets born to sows in the control and FA + antiinf groups (P = 0.08 
in both cases; Fig. 3B). Although some differences in Shannon index were observed in the piglets born to gilts, 
these differences were not statistically significant under any of the treatments. In addition, the richness of the 
faecal microbiota in the Amox group was lower than the control group (Chao, P = 0.016) but showed a trend to 
be higher than the Lys group (Chao, P = 0.08). When explored considering the parity of the dams (Supplemen-
tary Figure S1A), the lower richness in the Amox group compared to control group was only confirmed in ani-
mals born to gilts (P = 0.049). Also, FA + antiinf group showed lower richness than the control group (P = 0.05) 
considering only animals born to gilts. However, considering only animals born to sows other difference in 
richness became evident, i.e. Lys + FA group showed lower richness compared to Lys group (P = 0.047, Supple-
mentary Figure S1A). In general, pigs born to gilts had lower richness in the faecal microbiota than those born 
to sows (P = 0.037, Supplementary Figure S1B).
Alpha diversity of the nasal microbiota was also compared among the treatment groups on D21 (Fig. 4A). 
The FA + antiinf group showed the highest diversity when compared against all the other groups, including the 
control (P = 0.0004), although it was only a tendency when compared to the Amox group (P = 0.08). In contrast 
Figure 1.  Average daily weight gain (ADWG) of piglets fed with different additives. Each boxplot corresponds 
to one treatment group: Lys lysozyme, FA + lys medium chain fatty acids and lysozyme, C control, with no 
additives, Amox amoxicillin, FA + antiinf medium chain fatty acids and a natural antiinflammatory. Dotted lines 
represent the standard deviation and outliers are indicated with white circles.
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to what was observed in the faecal microbiota, the diversity of the group under antibiotic treatment (Amox) 
tended to be higher than the control group (P = 0.06). The analysis separating the piglets depending on the parity 
of the dams, revealed that this factor also affected the nasal composition (Fig. 4B). The nasal microbiota from 
piglets born to sows showed similar results than those obtained considering all the animals together, with the 
FA + antiinf group showing the highest diversity among all the treatments. The antibiotic treatment increased 
the diversity in the nasal microbiota in pigs born to sows (piglets from sows: Amox vs Control, P = 0.012) but 
it did not affect the diversity in pigs born to gilts (piglets from gilts: Amox vs control, P = 0.51). In general, the 
nasal diversity in piglets born to gilts was mildly affected by the treatment. Alpha diversity was higher in piglets 
born to gilts in the control and FA + antiinf groups, but no group showed significant differences when compared 
with the control group. However, alpha diversity in the nasal microbiota of piglets born to gilts from the FA + Lys 
group was significantly lower than their counterparts from the FA + antiinf group. Noteworthy, the comparison 
between piglets born to sows or gilts within treatments showed a different trend in the control group than in the 
rest of treatments (Fig. 4B). Control piglets from sows showed lower diversity than those from gilts (P = 0.09), 
while in the rest of treatments piglets from sows showed higher diversity than those from gilts, although this 
difference was only significant in the FA + antiinf group (P = 0.017).
In agreement with the higher alpha diversity found by Shannon index, groups FA + antiinf (FA + antiinf vs 
Lys P = 0.07; FA + antiinf vs FA + Lys P = 0.03; FA + antiinf vs control P = 0.07) and Amox (Amox vs Lys P = 0.01; 
Amox vs FA + lys P = 0.01; Amox vs control P = 0.016) showed the highest species richness in the nasal micro-
biota, with no differences between them. Considering the parity of the dams, we found the same trends when 
comparing only animals born to sows (i.e. both FA + antiinf and Amox groups showing the highest richness, 
Supplementary Figure S1C), while some of these differences were lost when considering only animals born to 
gilts only. In general, the parity of the dams affected the richness of the nasal microbiota composition of their 
offspring in the same way it affected the faecal microbiota, since animals born to gilts showed the lowest rich-
ness independently of the treatment group they belonged (gilts vs sows, P = 0.021; Supplementary Figure S1D).
Beta diversity of faecal and nasal microbiota composition after treatments. The PCoA of the 
faecal microbiota on D21 revealed that approximately 9% of the differences in microbiota composition could be 
explained by the treatment in both, quantitative and qualitative analyses (Bray Curtis  R2 = 9.50% P = 0.05; Jaccard 
 R2 = 9.21%, P = 0.01; Supplementary Figure S2). The pairwise PERMANOVA analysis on Bray Curtis distances 
revealed differences between some of the treatment groups, specially for Amox group (Lys vs Control, P = 0.06; 
Amox vs Lys + FA, P = 0.08; Amox vs Control, P = 0.08). When parity (gilts vs sows) was included in the analysis, 
Figure 2.  Alpha and beta diversity of faecal and nasal microbiota change through time. Alpha diversity 
estimated using Shannon’s index on rarefied samples from fecal content (A) or nasal swabs (B) compared before 
starting the treatment with feed addtives (D0) and after 21 days of treatment (D21). The dotted lines represent 
standard deviation and outliers are indicated with white circles. Beta diversity analysis on Bray Curtis’ distances 
of the faecal (C) and nasal (D) microbiota composition among samples collected at D0 and D21. The principal 
axis are shown with the percentage of variation explained between brackets. *** stands for P value < 0.001.
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Figure 3.  Alpha diversity of faecal microbiota is different depending on the treatment group. Diversity was 
estimated using Shannon’s index at D21 on faecal samples for the treatment groups (A) or considering the parity 
of the dams (B). The dotted lines represent standard deviation and outliers are indicated with white circles. 
The alpha significance is shown in the right panel indicating the P values, when significant. The treatment 
groups were: Lys lysozyme, FA + lys medium chain fatty acids and lysozyme, C control, with no additives, Amox 
amoxicillin, FA + antiinf medium chain fatty acids and a natural antiinflammatory; each group was splitted 
according the parity of their dams: gilts (first delivery) or sows (more than 1 delivery).
Figure 4.  Alpha diversity from nasal microbiota is different depending on the treatment group. Diversity was 
estimated using Shannon’s index at D21 on nasal samples for the treatment groups (A) or considering the parity 
of the dams (B). The dotted lines represent standard deviation and outliers are indicated with white circles. 
The alpha significance is shown in the right panel indicating the P values, when significant. The treatment 
groups were: Lys lysozyme, FA + lys medium chain fatty acids and lysozyme, C control, with no additives, Amox 
amoxicillin, FA + antiinf medium chain fatty acids and a natural anti-inflammatory; each group was splitted 
according the parity of their dams: gilts (first delivery) or sows (more than 1 delivery).
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the PCoA demonstrated that clustering by treatment was significant when considering the qualitative approach 
of the Jaccard index  (R2 = 19.61%, P = 0.036), but failed in a quantitative approach (Bray Curtis  R2 = 19.75%, 
P = 0.127). Interestingly, differences by treatment could be traced back mainly to the piglets born to gilts, since 
PCoA on these animals was significative in quantitative approach explaining a higher percentage of the differ-
ences (Bray Curtis  R2 = 40.25%, P = 0.05; Jaccard  R2 = 38.04%, P = 0.08). For the piglets born to sows, clustering 
was not explained by treatment using either qualitative or quantitative approaches (Jaccard P = 0.6, Bray Curtis 
P = 0.2).
The PCoA on the nasal microbiota composition showed that the FA + antiinf group was more homogenous, 
i.e. piglets in this group had a more similar microbiota composition among them, in contrast with the other 
groups (Supplementary Figure S3). When the clustering was analysed based on treatment group, the differences 
were better explained through quantitative (Bray Curtis  R2 = 23.71%, P = 0.001) than qualitative analysis (Jaccard 
 R2 = 15.04%, P = 0.001). When the clustering analysis was performed considering both the treatments and the 
parity of the dams (sows versus gilts) the differences were better explained (Bray Curtis  R2 = 33.26%, P = 0.001; 
Jaccard  R2 = 25.883%, P = 0.001), indicating that the parity of the dams had also an effect on the nasal microbiota. 
The pairwise PERMANOVA analysis over Bray Curtis distances showed that all the comparisons were statisti-
cally significant among all treatment groups (P < 0.01). Clustering by treatment was significatively explained in 
piglets from sows (Bray Curtis  R2 = 29.74%, P = 0.001; Jaccard  R2 = 18.84%, P = 0.001), as well as in piglets from 
gilts (Bray Curtis  R2 = 42.85%, P = 0.001; Jaccard  R2 = 36.97%, P = 0.001).
ANCOM was performed on samples from D21 to detect differentially abundant genera among treatments. 
When the faecal microbiota was compared across all the samples, only one genus, Mitsuokella was identified 
(Fig. 5). However, no genus was detected when the parity of the dams was included in the analysis. In addition, 
ANCOM was performed to detect differential abundant ASVs in the faecal microbiota under different treatments, 
but none was detected. When the parity of the dams was considered, one ASV classified in the Elusimicrobiaceae 
family was detected to be differentially abundant among the treatments (Fig. 6). This ASV was only detected in 
the faecal microbiota of the piglets from gilts in the Lys and FA + Lys treatments, although in very low abundance.
In the nasal microbiota, ANCOM detected that Helicobacter and an unclassified genus from the Weeksellaceae 
family were differentially abundant among the treatments (Fig. 7). When parity was included in the analysis, 
Lachnospira and an unclassified genus from Weeksellaceae were detected (Fig. 8). ANCOM was also performed 
to detect differential ASVs from the nasal microbiota and identified 2 ASVs from Lachnospiraceae and 1 ASV 
from Bacteroidales (Fig. 9). When parity was included in the analysis, 3 ASVs were detected: 1 from Clostridi-
ales, 1 from Lachnospiraceae (one of the two detected by treatment only) and 1 from Ruminococcaceae (Fig. 10).
Discussion
Antimicrobial metaphylaxis is still used as part of control programmes for respiratory diseases in conventional 
pig farming, and the treatment with broad spectrum beta-lactam antimicrobials is considered the most effective 
against S. suis  infections5. Efforts are being carried out by the swine sector to reduce the use of antimicrobials, 
but controlling the transmission of S. suis still represents a challenge, since this pathogen is widely distributed in 
the majority of pig  farms5. Accordingly, our study confirmed the presence of S. suis in nearly all piglets sampled 
at  weaning11. None of the treatments, including the antimicrobial, reduced the prevalence of colonization by S. 
suis, or by other potential pathogens, such as G. parasuis.
The productive performance of the piglets (ADWG) did not appear to be affected by any of the treatments. 
However, it is important to notice that diseased animals were excluded from the analysis of this parameter and, 
particularly, the control and the FA + antiinf groups had the highest number of animals removed (39 and 30, 
respectively). The ADWG values in these two groups were widely scattered, with large differences among animals. 
In contrast, ADWG was less dispersed in the Amox group. This farm was under the infection pressure of S. suis, 
and the effect of these additives on ADWG in a farm with a good health status would need to be evaluated to 
reach appropriate conclusions on this parameter. Additionally, animals were not followed until the end of the 
Figure 5.  Analysis of composition of microbiomes (ANCOM) on fecal microbiota at genus level comparing 
groups after treatment (D21). Mitsuokella genus was dected with this differential abundance test. The mean 
relative abundance of this genus is shown in percentage. Each boxplot corresponds to one treatment group: 
Lys lysozyme, FA + lys medium chain fatty acids and lysozyme, C control, with no additives, Amox amoxicillin, 
FA + antiinf medium chain fatty acids and a natural anti-inflammatory. The dotted lines represent standard 
deviation and outliers are indicated with white circles.
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rearing cycle, and therefore we cannot do any inference on the effect of the treatments at the end of the fattening 
period, which is the time when this value is more meaningful.
Since there is a call for reducing the use of antimicrobials in veterinary medicine, additives could be a poten-
tial alternative to the use of amoxicillin, which is known to favour emergence of resistant bacteria. Clinical 
signs compatible with S. suis obtained supplementing the food with medium chain fatty acids combined with 
a natural anti-inflammatory (FA + antiinf) were at the same level than those obtained with amoxicillin. High 
alpha diversity in the microbiota from different body sites, including the nose, was shown to be associated with 
good health in both, animal and human  hosts12–15. Nasal microbiota is probably important in the first steps of 
S. suis infection since the upper respiratory tract is a natural entry route for this  pathogen16. Accordingly, the 
group with the highest diversity of microbial communities in the nasal cavities was group FA + antiinf, which 
Figure 6.  Analysis of composition of microbiomes (ANCOM) on fecal microbiota comparing groups 
considering the parity of the dams after treatment (D21). The ANCOM at amplicon sequence (ASV) level 
detected an unclassified genus from Elusimicrobiacea family with differential abundance when compared 
groups considering the parity of their dams. The mean relative abundance of this ASV is shown in percentage. 
The dotted lines represent standard deviation and outliers are indicated with white circles. The treatment 
groups were: Lys lysozyme, FA + lys medium chain fatty acids and lysozyme, C control, with no additives, Amox 
amoxicillin, FA + antiinf medium chain fatty acids and a natural antiinflammatory; each group was splitted 
according the parity of their dams: gilts (first delivery) or sows (more than 1 delivery).
Figure 7.  Analysis of composition of microbiomes (ANCOM) on fecal microbiota at genus level comparing 
groups after treatment (D21). Helicobacter genus and unclassified member from Weeksellaceae family were 
dected with this differential abundance test. The mean relative abundance of these genera is shown in 
percentage. Each boxplot corresponds to one treatment group: Lys lysozyme, FA + lys medium chain fatty acids 
and lysozyme, C control, with no additives, Amox amoxicillin, FA + antiinf medium chain fatty acids and a 
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in turn showed the lowest S. suis disease prevalence. Regarding general health status (in this particular farm, 
clinical signs included limping and nervous signs, wasting, diarrhea and coughing), the results obtained in two 
treatment groups, Lys and FA + lys, were similar to the group treated with amoxicillin, confirming, once again, 
that the use of amoxicillin could be reduced. Unexpectedly, the nasal diversity was higher in the Amox group 
compared to the control. Since the nose is more exposed to environmental changes, the increased number of 
species detected could be a result of transient bacteria that are not actual colonizers, and do not find much 
competition in a microbiota depleted by the antimicrobial treatment. However, this effect was not observed in 
previous  studies17–19 and may depend on several factors, including the age of the animals, the type of antimicro-
bial or the duration of treatment. Hence, this intriguing finding deservers further investigation to understand 
this phenomenon in the nasal microbiota.
It is well established that the microbiota of the piglets evolves rapidly during the first weeks of life, increasing 
the diversity and community richness of bacterial  species20,21, as it was confirmed herein for faecal and nasal 
microbiota. Animal health and production during different growth stages have been correlated with components 
of the swine gut microbiome in several  studies22–24. At weaning, piglets’ diet changes from milk to dry food, and 
this has an impact in the bacterial communities of the  microbiota25,26. Among the major changes detected in 
the faecal microbiota composition along time, Prevotella and Bacteroides genera showed an opposite behaviour, 
increasing from a mean of 1.25–10.5% and decreasing from 18.3 to 0.52% respectively, in agreement to what was 
previously reported by Frese et al.22. The relative increased in Prevotella abundance may be essential for plant-
based digestion in post-weaning  piglets32. We also detected a decreasing tendency in Lactobacillus throughout 
time that might be also related to the changes in  feeding27, since members from this genus are early colonizers 
that depend on milk’s lactose, which are normally replaced by other genera later in  time28. Regarding major 
changes in nasal microbial composition after weaning, we found the same Bacteroides and Prevotella inverse 
apparent association observed in the faeces. Remarkably, several genera associated to health (such as Lachnospira 
and Blautia from Lachnospiraceae, and Faecalibacterium and Ruminococcus from Ruminococcaceae) relatively 
increased, probably promoting the immune and anti-stress  functions29, while Bergeyella and Fusobacterium, 
which have been associated to  disease30–32, showed to relatively decrease over time.
To our surprise, diet supplements did not have a major effect on the composition of the faecal microbiota, 
while the effect was more evident on the nasal microbiota composition. The only genus differentially present in 
the faecal microbiota when compared treatments, was Mitsuokella, which was only detected in FA + Lys group. 
This genus was associated to Prevotella as an important co-occurrent genus to define enterotype-like clustering 
structure of the faecal microbiota in  pigs33, revealing the importance of this genus. On the other hand, the analysis 
perform at ASV level showed one ASV from Elusimicrobiaceae family, which was only detected in the piglets 
Figure 8.  Analysis of composition of microbiomes (ANCOM) on nasal microbiota comparing groups 
considering the parity of the dams after treatment (D21). The ANCOM at genus level detected Lachnospira 
and an unclassified member from Weeksellaceae as differentially abundant. The mean relative abundance 
of these genera is shown in percentage. The dotted lines represent standard deviation and outliers are 
indicated with white circles. The treatment groups were: Lys lysozyme, FA + lys medium chain fatty acids and 
lysozyme, C control, with no additives, Amox amoxicillin, FA + antiinf medium chain fatty acids and a natural 
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born to gilts from groups Lys and Lys + FA in very low abundance. Noteworthy, members from this family have 
been negatively associated to backfat accumulation, average daily gain and residual feed intake in a study where 
feeding behaviour traits were under analysis in  pigs34. However, we did not observe differences in average daily 
weight gained when analysing this parameter by parity of the dams.
In the nasal microbiota, several genera were differentially abundant when treatments were compared, includ-
ing members of Weeksellaceae family. This family is found in high abundance in the nasal cavities of healthy 
piglets, although in increased relatively abundance in the core microbiota of animals with respiratory  disease32,35. 
Interestingly, this particular unclassified member from this family was in lower abundance in the nasal micro-
biota of pigs from the FA + antiinf group, which developed the lowest percentage of clinical signs compatible 
with S. suis disease. In contrast, the analysis at ASV level found one ASVs from Lachnospiraceae that was more 
relatively abundant in the FA + antiinf group. This opposite occurrence between these two taxa deserves further 
investigation to unveil the potential implications in animal health.
The distinctive clustering of both, faecal and nasal samples was explained by combining treatment and dam 
parity better than by just treatment. This analysis unveiled that parity of the dams impacted the development of 
the early microbiota. To the best of our knowledge, no other reports in the literature have described the effect of 
parity on the microbial composition of their offspring. However, several studies have reported increasing cases of 
diarrhea in litters born to  gilts36,37, which could be a consequence of a lower microbiota diversity. In general, we 
found that piglets born to gilts contained less microbial diversity in all treatment groups in the nasal and faecal 
microbiota, perhaps as a consequence of the antimicrobial treatment performed to gilts for aclimatation to the 
farm. Other factors can not be ruled out, suh as prenatal stress or milk quality. Prenatal stress has been demon-
strated to have an impact in microbial colonization in new-born  babies38, and this stress could be higher in gilts 
than in  sows39. Lactation has been shown to impact the neonatal microbiota, not only because of the abundant 
bacterial communities in milk, but also because milk is a rich and natural source of oligosaccharides that may 
have prebiotic  activity40. It is not known if the composition of the milk microbiota differs depending the parity 
of the dam, however this usually correlates with age, and the microbial communities change along time in many 
Figure 9.  Analysis of composition of microbiomes (ANCOM) on nasal microbiota comparing groups after 
treatment (D21). The ANCOM at amplicon sequence variant (ASV) level detected two unclassified members 
from Lachnospiraceae family and one member from Bacteroidales order as differentially abundant. The mean 
relative abundance of these ASVs is shown in percentage. Each boxplot corresponds to one treatment group: 
Lys lysozyme, FA + lys medium chain fatty acids and lysozyme, C control, with no additives, Amox amoxicillin, 
FA + antiinf medium chain fatty acids and a natural antiinflammatory. The dotted lines represent standard 
deviation and outliers are indicated with white circles.
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body  sites41. The development of the microbiota during early life sets the stage for the adult microbiome and can 
have long-term impacts on the health of the  host42,43. Therefore, specific interventions directed to gilts aiming 
at reducing stress and improve nutritional programmes by adding prebiotics or probiotics during gestation to 
promote the growth of beneficial bacteria would have a positive effect in the litter.
In conclusion, the use of amoxicillin resulted in a consistent reduction of clinical signs, but the evaluated 
additives have been shown to be a good alternative in the present scenario of reduction of antimicrobials. The 
feed supplementation with medium chain fatty acid and lysozyme improved clinical signs for general disease 
(coughing, diarrhea and wasting), whereas supplementation with medium chain fatty acids and a natural anti-
inflamatory reduced clinical signs compatible with S. suis. Interestingly, the effect of the feed additives was 
more significant in the nasal microbiota than in the faecal microbiota despite the oral administration of these. 
Moreover, sow parity influenced the microbiota composition in both faeces and nose. Taking together, these 
results highlight the importance of understading the dynamics of the microbiota, and the complexity of for-
mulating nutritional programs to manipulate the microbiota composition toward the right balance to improve 
health and prevent diseases.
Materials and methods
Study design. A farm with recurrent problems of disease confirmed to be caused by S. suis was selected for 
the study. Sampling of piglets was done under institutional authorization and followed good veterinary practices. 
According to European (Directive 2010/63/EU of the European Parliament and of the Council of 22 September 
2010 on the protection of animals used for scientific purposes) and Spanish (Real Decreto 53/2013) normatives, 
this procedure did not require specific approval by an Ethical Committee. Faecal and nasal sampling is not likely 
to cause pain, suffering, distress or lasting harm equivalent to, or higher than, that caused by the introduction of 
Figure 10.  Analysis of composition of microbiomes (ANCOM) on nasal microbiota comparing groups 
considering the parity of the dams after treatment (D21). The ANCOM at amplicon sequence variant (ASV) 
level detected two unclassified members, one from Lachnospiraceae and other from Ruminococcaceae family, and 
one member from Clostridiales order as differentially abundant. The mean relative abundance of these ASVs is 
shown in percentage. The dotted lines represent standard deviation and outliers are indicated with white circles. 
The treatment groups were: Lys lysozyme, FA + lys medium chain fatty acids and lysozyme, C control, with no 
additives, Amox amoxicillin, FA + antiinf medium chain fatty acids and a natural antiinflammatory; each group 
was splitted according the parity of their dams: gilts (first delivery) or sows (more than 1 delivery).
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a needle in accordance with good veterinary practice (Chapter I, Article 1, 5 (f) of 2010/63/EU). All experiments 
were performed in accordance with relevant guidelines and regulations.
A whole batch of new-born piglets from 54 dams were designated to take part in the study. Dams included 
did not take any medication 15 days prior farrowing or during farrowing. One-day-old piglets were ear-tagged 
and the routine procedure established by the veterinarian of the farm in terms of vaccination (circovirus vaccine 
at 3 weeks of age) was carried out.
One week before weaning, all piglets (n = 569) were ear-tagged on the second ear and animals were weighed. 
Piglets were randomly distributed into five experimental groups by dam’s origin (balanced proportion of piglets 
of each dam in each of the experimental group) and weight (same average weight per group). For analysis of S. 
suis and Glaesserella (Haemophilus) parasuis nasal colonization in the different treatment groups, a subset of 125 
piglets were randomly selected representing one piglet per litter in each of the treatment-groups (25 piglets per 
treatment). Cross-fostered piglets were not included in this selection. Nasal samples were taken in this subset of 
animals at weaning (D0) and after 3 weeks of treatment (D21). Additionally, nasal and faecal samples were taken 
from a subset of 12 piglets at D0 and 10 piglets per group at D21 for microbiota analysis.
Twenty-one days-old piglets were weaned and moved from the farrowing unit and allocated into 5 groups. 
Five different treatments (two treatments per room) were assigned; treatments Lys (feed supplemented with 
lysozyme, both free and encapsulated, n = 113), FA + Lys (feed supplemented with medium chain fatty acids 
(FA) and lysozyme, n = 110), Amox (in-feed amoxicillin, n = 115), and FA + antiinf (feed supplemented with 
Naturporc, containing medium chain FA and a natural anti-inflammatory, n = 119). Also a control group of 
piglets was included (control feed with no additives, n = 112).
Animals were followed up daily by the personnel at the farm; however, a closer clinical evaluation was per-
formed every two days by the veterinarian until departure to the fattening farm. Recording of clinical signs was 
carried out individually. Based on the veterinarian assessment, animals that needed antibiotic treatment during 
the course of the study were removed and the cause of removal was annotated. Three animals were euthanized and 
sampled during the study period, two of them presenting clinical signs compatible with the presence of S. suis, 
which were limping and nervous signs. Animals that died during the study were also recorded and the presump-
tive cause of dead was annotated in the database. To avoid subjected interpretation of results, the veterinarian 
and personnel at the farm were unaware of the additives used in each of the treatment groups. All animals in the 
five groups (n = 434) were weighed at the end of the study period (day 43).
Isolation and identification of S. suis and G. parauis. Individual nasal swabs were taken in two dif-
ferent occasions from the subset of 125 pigs and kept at -80ºC until analysis at the end of the study. Nasal swabs 
were resuspended in PBS and DNA was extracted using a NucleoSpin Blood kit (Macherey–Nagel, Germany) 
following manufacturer´s recommendations. DNA was tested for the presence of S. suis and G. parasuis with 
primers and conditions described  before44,45. PCR for G. parasuis has been designed to detect virulence-asso-
ciated trimeric autotransporters (vtaA) genes associated to G. parasuis virulent  strains45. Although S. suis was 
suspected to be the cause of disease in this specific farm, G. parasuis was included in the diagnosis since the 
clinical signs of both infections are similar and both pathogens affect piglets of the same age, mainly piglets in 
the nursery phase.
Swabs obtained from the foramen magnum of sacrificed pigs with clinical signs compatible with infection by 
S. suis were plated in chocolate agar (Biomerieux, Spain) and incubated overnight at 37 C with 5%  CO2. Once 
the presence of S. suis was confirmed, identification of serotypes 2 and 9 was assessed as described  elsewhere46.
S. suis isolated strains were genotyped by ERIC-PCR in order to assess the presence of different disease-
causing strains on the farm, as was described by Versalovic et al.47.
Antimicrobial susceptibility testing. Antimicrobial susceptibility testing was performed by broth 
microdilution methods using commercial plates (Sensititre) and following guidelines described by the Clini-
cal and Laboratory Standards Institute (CLSI). Antimicrobials tested were chlortetracycline (0.5–8 mg/L), oxy-
tetracycline (0.5–8  mg/L), florphenicol (0.25–8  mg/L), penicillin (0.12–8  mg/L), ampicillin (0.25–16  mg/L), 
ceftiofur (0.25–8  mg/L), gentamicin (1–16  mg/L), neomycin (4–32  mg/L), spectinomycin (8–64  mg/L), tia-
mulin (1–32  mg/L), sulphadimethoxine (256  mg/L), trimethoprim/sulfamethoxazole (2/38  mg/L), tylosine 
(0.5–32 mg/L), tulathromycin (1–4 mg/L), tilmicosin (4–64 mg/L), clindamycin (0.25–16 mg/L), danofloxacin 
(0.12–1 mg/L) and enrofloxacin (0.12–2 mg/L). Clinical breakpoints were described by CLSI (CLSI, 2020).
Statistical analyses. The prevalences of disease compatible with S. suis infection (based on clinical signs) 
in the different treatment groups first compared with the prevalences of disease attributed to S. suis in both, the 
group treated with amoxicillin and the negative control group. Comparisons were carried out using the Pearson’s 
Chi-squared test.
Similar comparisons were carried out but using the total prevalence of disease in the different treatment 
groups. The total prevalence included not only disease caused by S. suis, but also wasting, diarrhea and/or cough-
ing. Comparisons were also carried out using the Pearson’s Chi-squared test.
Finally, the average daily weight gain in the five treatment groups were also compared. In order to do that, 
the normality of data in the different groups was assessed using the Shapiro–Wilk test. In case of normally dis-
tributed data, the weights were compared with an Anova test, with a post-hoc Tukey test to adjust for multiple 
comparisons when the Anova test was statistically significant. In case of non-normally distributed data, the 
weights in the different groups were compared with a Kruskal–Wallis test, with a post-hoc Dunn’s test with 
Bonferroni correction to adjust for multiple tests when the Kruskal–Wallis test was statistically significant. The 
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significance level (P value) was set at 0.05. All the statistical analyses were carried out using R statistical software 
(https ://cran.r-proje ct.org/).
Microbiota analyses. A subset of 10 clinically healthy individuals per treatment group representing litters 
from 10 different dams and proportionally balanced in the five treatment groups were selected for nasal and 
faecal microbiota analyses. Nasal swabs and faecal contents were obtained after three weeks to assess the effect 
of the different treatments on the microbiota. As control, nasal and faecal samples from 12 piglets obtained at 
weaning (D0), representing the microbiota composition before the treatments started, were also included in the 
analysis. Bacterial DNA was extracted from 0.2 g of homogenised faeces using a NucleoMag VET kit (Cultek) 
following the manufacturer’s instructions. DNA from nasal swabs was extracted as stated above with a Nucle-
oSpin Blood kit (Macherey–Nagel, Germany). Quality and quantity of DNA were evaluated on a BioDrop DUO 
(BioDrop Ltd, Cambridge. UK). The library preparation for sequencing was performed at The Carver Biotech-
nology Center (University of Illinois, United States) for rectal samples and at Servei de Genòmica (Universitat 
Autònoma de Barcelona) for nasal samples. In either case, sequencing of 16S rRNA gene was done with Illumina 
MiSeq pair-end 2 × 250 bp technology following the manufacturer instructions (MS-102-2003 MiSeq Reagent 
Kit v2, 500 cycle). The region targeted to perform the 16S amplification was the one spanning the V3 and V4 
region of 16S rRNA gene selected from Klindworth et al.48.
For the taxonomic analysis, both Qiime2 v2019.1049 and in-house scripts were used. Raw reads were evaluated 
and quality-filtered with q2-demux plugin. Trimming and denoising with  DADA250 allowed the identification 
of amplicon sequence variants (ASVs). ASVs were aligned using  MAFFT51 and a phylogenetic tree was built 
using  Fasstree252. Taxonomic assignment was performed with q2‐feature‐classifier53 classify‐sklearn naïve Bayes 
taxonomy classifier against the Greengenes (version 13.8)  database54.
Alpha diversity indexes (Shannon, Chao) were calculated on rarefied 16S rRNA gene sequence data at maxi-
mum depth for all samples (which was 8500 from rectal samples and 19,000 for nasal samples). Alpha diversity 
between groups was compared through two-sample non-parametric t-tests (Monte Carlo method) at maximum 
depth in rarefied samples (with 999 permutations). In addition, equal number of samples was subsampled to 
assess the significant differences between sample types. The plugin q2-diversity core-metrics was used to both, 
estimate beta diversity metrics and perform Principal Coordinate Analysis (PCoA). We used different metrics 
to represent the differences in community composition, where Jaccard reports differences in the presence or 
absence of ASVs, Bray–Curtis accounts for these differences but also includes abundance of the ASVs. PCoA 
were visualized using  EMPeror55. The percentage of variation between grouped samples was measured by R2, 
using Adonis function of the vegan package in R  software56. Estimation of P values was done through Monte 
Carlo test with 999 random permutations of the data set. Permutational analysis of the variance (PERMANOVA) 
was performed to compare beta diversity matrices over the treatments under study with 999  permutations57 (q2 
diversity beta-group-significance). In order to identify differentially abundant taxa between treatment groups, the 
test of analysis of composition in microbiomes (ANCOM) was used on the tables previously filtered by frequency 
(n > 10) and collapsed by genus (L6). Boxplots were built using boxplots  function58–60 in  R61. In all cases, samples 
were considered to be significantly different when the accompanying P value was ≤ 0.05.
Data availability
The entire sequence dataset is available in the Sequence Read Archive (SRA) database from NCBI, BioProject 
PRJNA632930 and BioSamples SAMN14928473-14928596.
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